SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 229 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,798,387 | -51.6% | 2,997,926 | +5.0% | 0.00% | – |
| Q2 2023 | $3,712,477 | -18.5% | 2,855,752 | +10.3% | 0.00% | -100.0% |
| Q1 2023 | $4,557,222 | +58079.8% | 2,589,331 | +3.8% | 0.00% | 0.0% |
| Q4 2022 | $7,833 | -99.9% | 2,494,871 | +4.7% | 0.00% | -50.0% |
| Q3 2022 | $11,673,000 | +30.0% | 2,382,435 | +9.8% | 0.00% | +100.0% |
| Q2 2022 | $8,979,000 | -26.1% | 2,169,013 | +3.7% | 0.00% | -50.0% |
| Q1 2022 | $12,156,000 | -27.3% | 2,092,371 | -6.1% | 0.00% | 0.0% |
| Q4 2021 | $16,718,000 | -15.5% | 2,229,183 | +1.5% | 0.00% | -33.3% |
| Q3 2021 | $19,780,000 | -19.8% | 2,195,343 | +6.5% | 0.00% | 0.0% |
| Q2 2021 | $24,664,000 | -0.6% | 2,060,536 | +4.1% | 0.00% | -25.0% |
| Q1 2021 | $24,808,000 | -12.4% | 1,979,960 | +9.1% | 0.00% | -20.0% |
| Q4 2020 | $28,319,000 | +70.4% | 1,814,837 | +3.2% | 0.01% | +66.7% |
| Q3 2020 | $16,620,000 | +4.7% | 1,758,834 | -0.8% | 0.00% | 0.0% |
| Q2 2020 | $15,881,000 | +47.6% | 1,772,502 | +4.9% | 0.00% | 0.0% |
| Q1 2020 | $10,759,000 | -59.4% | 1,689,025 | -46.7% | 0.00% | 0.0% |
| Q4 2019 | $26,524,000 | +91.2% | 3,169,138 | +106.7% | 0.00% | 0.0% |
| Q3 2019 | $13,873,000 | -13.3% | 1,532,968 | +3.2% | 0.00% | -25.0% |
| Q2 2019 | $16,005,000 | +34.0% | 1,486,150 | +18.7% | 0.00% | +33.3% |
| Q1 2019 | $11,948,000 | -53.9% | 1,252,473 | -44.5% | 0.00% | -25.0% |
| Q4 2018 | $25,930,000 | +37.4% | 2,258,730 | +102.8% | 0.00% | -20.0% |
| Q3 2018 | $18,875,000 | +22.9% | 1,113,615 | +3.0% | 0.01% | 0.0% |
| Q2 2018 | $15,357,000 | -3.5% | 1,081,568 | +29.1% | 0.01% | 0.0% |
| Q1 2018 | $15,921,000 | +15.6% | 837,995 | -0.3% | 0.01% | 0.0% |
| Q4 2017 | $13,777,000 | +11.9% | 840,104 | +2.3% | 0.01% | 0.0% |
| Q3 2017 | $12,315,000 | +92.3% | 821,017 | +12.8% | 0.01% | +66.7% |
| Q2 2017 | $6,403,000 | +94.3% | 727,615 | +14.8% | 0.00% | +200.0% |
| Q1 2017 | $3,296,000 | +75.9% | 633,964 | +3.1% | 0.00% | 0.0% |
| Q4 2016 | $1,874,000 | -21.0% | 614,633 | +19.9% | 0.00% | 0.0% |
| Q3 2016 | $2,373,000 | -18.1% | 512,638 | +2.5% | 0.00% | -50.0% |
| Q2 2016 | $2,896,000 | -1.3% | 500,351 | +3.2% | 0.00% | 0.0% |
| Q1 2016 | $2,933,000 | -29.9% | 484,858 | +5.7% | 0.00% | 0.0% |
| Q4 2015 | $4,186,000 | +71.6% | 458,557 | +6.0% | 0.00% | +100.0% |
| Q3 2015 | $2,440,000 | -48.9% | 432,670 | +0.5% | 0.00% | -66.7% |
| Q2 2015 | $4,776,000 | -25.9% | 430,676 | +4.8% | 0.00% | -25.0% |
| Q1 2015 | $6,445,000 | +4.0% | 411,127 | +0.9% | 0.00% | 0.0% |
| Q4 2014 | $6,196,000 | +29.0% | 407,400 | -8.5% | 0.00% | +33.3% |
| Q3 2014 | $4,803,000 | -18.2% | 445,345 | +15.8% | 0.00% | -25.0% |
| Q2 2014 | $5,871,000 | -11.4% | 384,501 | +5.0% | 0.00% | 0.0% |
| Q1 2014 | $6,623,000 | +38.6% | 366,361 | +6.5% | 0.00% | +33.3% |
| Q4 2013 | $4,777,000 | +73.7% | 343,988 | +31.1% | 0.00% | +50.0% |
| Q3 2013 | $2,750,000 | +60.0% | 262,347 | +19.2% | 0.00% | 0.0% |
| Q2 2013 | $1,719,000 | – | 220,076 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,000,000 | $66,540,000 | 6.69% |
| FIC CAPITAL INC | 787,529 | $8,734,000 | 3.47% |
| RA Capital Management | 1,220,209 | $13,532,000 | 1.36% |
| PRINCETON CAPITAL MANAGEMENT INC | 114,120 | $1,266,000 | 0.67% |
| Perceptive Advisors | 800,000 | $8,872,000 | 0.53% |
| Cormorant Asset Management, LP | 361,000 | $4,003,000 | 0.53% |
| Highlander Capital Management, LLC | 43,500 | $482,000 | 0.43% |
| APEX CAPITAL, LLC | 439,900 | $4,878,000 | 0.42% |
| WASATCH ADVISORS LP | 3,091,386 | $34,283,000 | 0.37% |
| Baker Brothers Advisors | 3,230,932 | $35,831,000 | 0.31% |